Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nancy Miller-Rich Insider Profile
4 Followers
Nancy Miller-Rich, Director at Intercept Pharma, holds 922.00 shares in Aldeyra Therapeutics (Ticker: ALDX), holds 30.41K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Kadmon Holdings (Ticker: KDMN). Most recently, Nancy Miller-Rich Bought ― shares of Aldeyra Therapeutics on Oct 21, 2024 for an estimated value of 10.45K.
Nancy Miller-Rich Intercept Pharma (ICPT)Director
Intercept Pharma (ICPT)
Director
Not Ranked
Nancy Miller-Rich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nancy Miller-Rich holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nancy Miller-Rich
Nancy Miller-Rich's Trading History
Intercept Pharma
May 25, 2023
―
Uninformative Buy
―
$577.88K
Aldeyra Therapeutics
Oct 21, 2024
Director
Informative Buy
10.45K
$4.38K
Kadmon Holdings
―
―
―
―
4D Molecular Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Nancy Miller-Rich's performance on stock
You May Also Like
Nancy Miller-Rich insider profile FAQ
What is the percentage of profitable transactions made by Nancy Miller-Rich?
The percentage of profitable transactions made by Nancy Miller-Rich is ―.
What is the average return per transaction made by Nancy Miller-Rich?
The average return per transaction made by Nancy Miller-Rich is ―.
What stocks does Nancy Miller-Rich hold?
Nancy Miller-Rich holds: ICPT, ALDX, KDMN, FDMT stocks.
What was Nancy Miller-Rich’s latest transaction?
Nancy Miller-Rich latest transaction was an Informative Buy of $10.45K.
What was Nancy Miller-Rich's most profitable transaction?
Nancy Miller-Rich’s most profitable transaction was an Informative Buy of ALDX stock on October 21, 2024. The return on the trade was -0.10%.
What is Nancy Miller-Rich's role in Intercept Pharma?
Nancy Miller-Rich's role in Intercept Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.